NCT00005829View on ClinicalTrials.gov

Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

October 31, 2002

Study Completion Date

April 30, 2008

Conditions
Leukemia
Interventions
DRUG

gemcitabine hydrochloride

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00005829 - Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter